Organic–inorganic nanovesicles for doxorubicin storage and release
Source abstract
Abstract
The potential of organic–inorganic liposomal cerasomes to store and release doxorubicin (DOX) is investigated. Specifically, cerasomes display sustained DOX release in serum-enriched cell culture medium but minimal drug leakage in deionized water. As revealed by a physics-based model, the medium-sensitive DOX release/leakage is attributed to serum-mediated dissociation of DOX molecules. DOX-loaded cerasomes effectively inhibit the proliferation of human prostate cancer DU145 cells. Furthermore, the kinetics of cerasome uptake/internalization and DOX release correlates well with the time scale for DOX-loaded cerasomes to inhibit the proliferation of the DU145 cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Supramolecular Self-Assembly in Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Feldman · Nat. Rev. Cancer · 2001 · 1 · 3410.1038/35094009 ↗
2. Heidenreich · Cancer · 2004 · 101 · 94810.1002/cncr.20455 ↗
3. Das · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 1820210.1073/pnas.1006965107 ↗
4. Singal · N. Engl. J. Med. · 1998 · 339 · 90010.1056/NEJM199809243391307 ↗
5. Janes · J. Controlled Release · 2001 · 73 · 25510.1016/S0168-3659(01)00294-2 ↗
6. Yoo · J. Controlled Release · 2002 · 82 · 1710.1016/S0168-3659(02)00088-3 ↗
7. Abraham · Methods Enzymol. · 2005 · 391 · 7110.1016/S0076-6879(05)91004-5 ↗
8. Torchilin · Nat. Rev. Drug Discovery · 2005 · 4 · 14510.1038/nrd1632 ↗
9. Gabizon · Adv. Drug Delivery Rev. · 1997 · 24 · 33710.1016/S0169-409X(96)00476-0 ↗
10. Chang · Expert Opin. Drug Delivery · 2008 · 5 · 131310.1517/17425240802544159 ↗
11. Allen · Cancer Research · 1992 · 52 · 2431
12. Roux · J. Controlled Release · 2004 · 94 · 44710.1016/j.jconrel.2003.10.024 ↗
13. Katagiri · J. Am. Chem. Soc. · 2002 · 124 · 789210.1021/ja0259281 ↗
14. Matsui · J. Am. Chem. Soc. · 2006 · 128 · 311410.1021/ja058016i ↗
15. Zha · Adv. Mater. · 2011 · 23 · 343510.1002/adma.201101516 ↗
16. Zhang · Appl. Phys. Lett. · 2011 · 99 · 10370210.1063/1.3635783 ↗
17. Kawataki · Chem. Lett. · 2011 · 40 · 46110.1246/cl.2011.461 ↗
18. Barenholz · Curr. Opin. Colloid Interface Sci. · 2001 · 6 · 6610.1016/S1359-0294(00)00090-X ↗
19. Chen · Int. J. Pharm. · 2009 · 366 · 13310.1016/j.ijpharm.2008.09.009 ↗
20. Mayhew · Exp. Cell Res. · 1987 · 171 · 19510.1016/0014-4827(87)90262-X ↗
21. Katagiri · Chem.–Eur. J. · 2007 · 13 · 527210.1002/chem.200700175 ↗
22. Tsukioka · Cancer Sci. · 2002 · 93 · 114510.1111/j.1349-7006.2002.tb01217.x ↗
23. Cao · Chem. Commun. · 2010 · 46 · 526510.1039/b926367e ↗
24. Comiskey · Biochemistry · 1990 · 29 · 362610.1021/bi00467a006 ↗
25. Buyens · J. Controlled Release · 2008 · 126 · 6710.1016/j.jconrel.2007.10.024 ↗
26. Zeng · Appl. Phys. Lett. · 2010 · 97 · 07370110.1063/1.3479924 ↗
27. Teng · J. Controlled Release · 2011 · 156 · 18610.1016/j.jconrel.2011.07.036 ↗
28. Zeng · Journal of Drug Delivery · 2011 · 370308
29. Moreira · Braz. J. Med. Biol. Res. · 2004 · 37 · 118510.1590/S0100-879X2004000800008 ↗
30. Delean · American Journal of Physiology · 1978 · 235 · E97
31. Huth · J. Controlled Release · 2006 · 110 · 49010.1016/j.jconrel.2005.10.018 ↗
32. Rajendran · Nat. Rev. Drug Discovery · 2010 · 9 · 2910.1038/nrd2897 ↗
33. Zitzmann · FASEB J. · 2010 · 24 · 186610.1096/fj.09-145755 ↗
34. Mayer · Anal. Biochem. · 1995 · 232 · 14910.1006/abio.1995.0001 ↗
35. Nii · Int. J. Pharm. · 2005 · 298 · 19810.1016/j.ijpharm.2005.04.029 ↗
36. Qiu · Int. J. Pharm. · 2008 · 361 · 5610.1016/j.ijpharm.2008.05.010 ↗
37. Guo · Langmuir · 2009 · 25 · 1311410.1021/la9034112 ↗
38. Xiong · Pharm. Res. · 2005 · 22 · 93310.1007/s11095-005-4588-x ↗
39. Banerjee · Int. J. Cancer · 2004 · 112 · 69310.1002/ijc.20452 ↗